Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trialsSchmitt, J. ; Rosumeck, S. ; Thomaschewski, G. ; Sporbeck, B. ; Haufe, E. ; Nast, A.British journal of dermatology (1951), 2014-02, Vol.170 (2), p.274-303 [Periódico revisado por pares]Oxford: Blackwell Publishing LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational studyEsposito, M. ; Gisondi, P. ; Cassano, N. ; Ferrucci, G. ; Del Giglio, M. ; Loconsole, F. ; Giunta, A. ; Vena, G.A. ; Chimenti, S. ; Girolomoni, G.British journal of dermatology (1951), 2013-09, Vol.169 (3), p.666-672 [Periódico revisado por pares]Oxford: Blackwell Publishing LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Antidrug antibodies in psoriasis: a systematic reviewHsu, L. ; Snodgrass, B.T. ; Armstrong, A.W.British journal of dermatology (1951), 2014-02, Vol.170 (2), p.261-273 [Periódico revisado por pares]Oxford: Blackwell Publishing LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgarisGniadecki, R. ; Kragballe, K. ; Dam, T.N. ; Skov, L.British journal of dermatology (1951), 2011-05, Vol.164 (5), p.1091-1096 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE networkvan den Reek, J.M.P.A. ; Zweegers, J. ; Kievit, W. ; Otero, M.E. ; van Lümig, P.P.M. ; Driessen, R.J.B. ; Ossenkoppele, P.M. ; Njoo, M.D. ; Mommers, J.M. ; Koetsier, M.I.A. ; Arnold, W.P. ; Sybrandy-Fleuren, B.A.M. ; Kuijpers, A.L.A. ; Andriessen, M.P.M. ; van de Kerkhof, P.C.M. ; Seyger, M.M.B. ; de Jong, E.M.G.J.British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1189-1196 [Periódico revisado por pares]Oxford: Blackwell Publishing LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasisStrober, B.E. ; Crowley, J.J. ; Yamauchi, P.S. ; Olds, M. ; Williams, D.A.British journal of dermatology (1951), 2011-09, Vol.165 (3), p.661-668 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trialsReich, K. ; Burden, A.D. ; Eaton, J.N. ; Hawkins, N.S.British journal of dermatology (1951), 2012-01, Vol.166 (1), p.179-188 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasisGottlieb, A.B. ; Langley, R.G. ; Strober, B.E. ; Papp, K.A. ; Klekotka, P. ; Creamer, K. ; Thompson, E.H.Z. ; Hooper, M. ; Kricorian, G.British journal of dermatology (1951), 2012-09, Vol.167 (3), p.649-657 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasisGottlieb, A.B. ; Leonardi, C. ; Kerdel, F. ; Mehlis, S. ; Olds, M. ; Williams, D.A.British journal of dermatology (1951), 2011-09, Vol.165 (3), p.652-660 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reductionPapp, K.A. ; Tyring, S. ; Lahfa, M. ; Prinz, J. ; Griffiths, C.E.M. ; Nakanishi, A.M. ; Zitnik, R. ; Van De Kerkhof, P.C.M.British journal of dermatology (1951), 2005-06, Vol.152 (6), p.1304-1312 [Periódico revisado por pares]Oxford, UK: Blackwell Science LtdTexto completo disponível |